Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Beam Therapeutics Inc
(NQ:
BEAM
)
25.12
+0.62 (+2.53%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Beam Therapeutics Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Credit Suisse Maintains Neutral Rating for Beam Therapeutics: Here's What You Need To Know
August 09, 2023
Via
Benzinga
Beam Therapeutics Reports Pipeline Updates and Second Quarter 2023 Financial Results
August 08, 2023
From
Beam Therapeutics
Via
GlobeNewswire
2 Supercharged Growth Stocks That Could Make You Richer
July 15, 2023
These two companies could disrupt healthcare on a global scale.
Via
The Motley Fool
3 Pharma Stocks That AI is Loving in July
July 13, 2023
Artificial intelligence recommends that these are the three stocks to consider when investing in pharma stocks.
Via
InvestorPlace
Verve Therapeutics Gains 20.74% In June as Ark Funds Invest
June 30, 2023
Verve Therapeutics' efforts to eliminate cardiovascular disease through gene-editing treatments have momentum, as the stock gets a 20.74% boost in June.
Via
MarketBeat
Beam Therapeutics: Q1 Earnings Insights
May 10, 2023
Via
Benzinga
Where Beam Therapeutics Stands With Analysts
March 21, 2023
Via
Benzinga
Where Beam Therapeutics Stands With Analysts
March 01, 2023
Via
Benzinga
Here's the Secret Behind Cathie Wood's Latest Moneymaking Strategy
June 18, 2023
Success could be in the DNA of the Ark Invest founder.
Via
The Motley Fool
Cathie Wood Is Buying This Biotech Stock Like Wildfire, But Should You?
May 21, 2023
It's facing a few issues that are practically guaranteed to affect shareholder returns.
Via
The Motley Fool
Beam Therapeutics to Participate in Upcoming May Investor Conferences
May 17, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Cathie Wood Is Loading Up on These 3 Stocks Down 70% or More. Should You?
May 16, 2023
The Ark Invest CEO is betting on rebounds for these beaten-down stocks.
Via
The Motley Fool
Beam Therapeutics to Participate in RBC Capital Markets 2023 Global Healthcare Conference
May 11, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Beam Therapeutics Reports Pipeline Updates and First Quarter 2023 Financial Results
May 10, 2023
From
Beam Therapeutics
Via
GlobeNewswire
7 Best Cathie Wood Stocks for Your May 2023 Buy List
May 02, 2023
This year promises to be very different for Cathie Wood stocks, as signs of economic improvement become more prominent.
Via
InvestorPlace
3 Growth Stocks Cathie Wood Just Bought That Could Be Absolute Game-Changers
May 02, 2023
Cathie Wood is loading up on these biotech stocks.
Via
The Motley Fool
The 3 Most Promising Gene Editing Stocks to Buy in 2023
April 28, 2023
Intellia, Beam, and Editas are using gene editing to cure incurable diseases. These are three gene editing stocks you'll want to invest in.
Via
InvestorPlace
Cathie Wood Is Unstoppable With Tesla Stock – Defies Wall Street To Make Whopping $29M Purchase
April 26, 2023
Via
Benzinga
3 Stocks to Watch in April: Is it Time to Buy?
April 18, 2023
With several fundamental factors pushing against the equities sector, these stocks to watch in particular draw significant intrigue.
Via
InvestorPlace
7 Top Growth Stocks to Buy for the Next Decade
April 18, 2023
These Growth Stocks to Buy Don't Require a 10-year Horizon But Should be More Valuable Then
Via
InvestorPlace
Cathie Wood Loads Up On Biotech Stocks — Continues To Raise Stake In Coinbase Global
April 06, 2023
Via
Benzinga
7 Biotech Stocks to Buy for Breakthrough Treatments and Cures
March 29, 2023
For those that can handle the heat, these biotech stocks to buy undergird some of the most powerful innovations in medicine.
Via
InvestorPlace
Beam Therapeutics to Participate in the Guggenheim 2023 Genomic Medicines and Rare Disease Day
March 27, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For March 21, 2023
March 21, 2023
Via
Benzinga
Beam Therapeutics Appoints Gopi Shanker, Ph.D., as Chief Scientific Officer
March 21, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Beam Therapeutics to Participate in the Barclays 2023 Global Healthcare Conference
March 15, 2023
From
Beam Therapeutics
Via
GlobeNewswire
3 CRISPR Gene Editing Stocks to Consider for Ground-Floor Investing
March 06, 2023
CRISPR Therapeutics, Beam Therapeutics and Vertex Pharmaceuticals are three CRISPR gene editing stocks you won't want to miss out on.
Via
InvestorPlace
3 Game-Changing Stocks to Buy in March
March 04, 2023
Innovation is in these companies' DNA.
Via
The Motley Fool
The Top 7 Growth Stocks in Biotech
March 03, 2023
The biotech sector always houses a great selection of growth stocks that can grow rapidly and reward investors over the long-term.
Via
InvestorPlace
Beam Therapeutics to Participate in the 43rd Annual Cowen Healthcare Conference
March 01, 2023
From
Beam Therapeutics
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.